On Tuesday, the S&P 500 (SPY) hit a fresh all-time high. With many factors to contribute to the market’s latest bull run, the technology sector takes the cake for a large portion of the rally. But, there are other sectors that are also responsible for driving the market higher. Currently, the healthcare sector is (SPY)’s … Continue reading Are These Biotech Stocks On Your Watch-List?
When investors think about a play in biotechs, often the biggest names probably come to mind first. Thoughts of Pfizer (PFE), Gilead (GILD) and Novartis (NVS) naturally may be running through one’s head. But, keep in mind that smaller biotechs could have the ability to deliver just as big of impact to their investors as … Continue reading 3 Biotech Stocks That May Have Buy-Out Potential
The increase of the aging population presents immense opportunities for bio-pharmaceutical companies to develop candidates to treat global ailments. Dozens of biotech stocks continue to generate significant gains for investors and as the average lifespan continues to increase, the number of drugs being developed to hit the market should follow. The potential for share prices … Continue reading 3 Biotech Stocks You Should Be Watching
Biotech companies are refusing to be bested by recreational weed. Cannabis has become the latest buzzword. All summer it has been all anyone could talk about. Headlines were dominated by US states’ continued legalization and Canada’s historic Bill C-45. Now, with the launch of the recreational market underway, everyone from alcohol distribution companies to beauty … Continue reading Stocks to Watch: Biotech Companies Refusing to be Bested by Recreational Weed
Stocks opened higher Tuesday, even amid some hard hits from China-based names, as the market looked pull ahead. Earnings season continues to roll on this week as a number of companies report quarterly results. Leading into the mid morning session, the S&P 500 index is up higher than Monday’s closing level. Hovering in the wings … Continue reading 3 Stocks To Watch With New Highs This Month
US tax reform has sparked a fresh wave of M&A in the biotech sector, representing a trend that Biotech Growth Trust manager Geoff Hsu believes has further to run and hopes to exploit after a difficult year for the investment trust. Hsu notes that M&A in the sector was lower than expected last year, as a result … Continue reading 3 Biotech Stocks Leading The Bull-Charge This Month
Healthcare and biotechnology have not faltered during recent weeks. No matter what announcements have come up regarding the potential trade war, stocks in this sector have continued to rally this summer. A number of mid and late stage biotech stocks have begun reporting pivotal research progress that could help bolster more attention in the market. … Continue reading 3 Biotech Stocks See Healthy Progress This Month
What To Pay Attention To & Why Biotech Is The Industry To Watch Right Now Over the last 3 months, the Health Care Select Sector SPDR Fund (XLV) has been climbing back toward its 52 week high. Both the SPDR S&P Biotech ETF (XBI) and the iShares NASDAQ Biotechnology Index ETF (IBB) have maintain their … Continue reading Industry Report: Is Biotech Part Of Your Portfolio Yet?
Both the SPDR S&P Biotech ETF (XBI) and the iShares NASDAQ Biotechnology Index ETF (IBB) extended gains on Thursday afternoon. Both funds have been in an uptrend for the better part of the last 3 days to begin the month of August. XBI + IBB Daily Chart As Of 8–3–2018 For a number of companies, earnings have taken … Continue reading 3 Biotech Stocks You Might Have Missed For Your August Watchlist
The Nasdaq iShares Biotechnology Index (IBB) has taken a turn toward “greener pastures”. The ETF rose by more than 1.2% on Tuesday as a number of biotech stocks moved higher in early morning trading. Additionally, a number of other ETF’s tracking the healthcare and biotech sectors have reversed from bearish trends and are heading higher … Continue reading Thursday Industry Report: 3 Biotech Stocks In Focus On Thursday